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Abstract
Background: The rodent malaria parasite Plasmodium chabaudi has proven of great value in the
analysis of fundamental aspects of host-parasite-vector interactions implicated in disease pathology
and parasite evolutionary ecology. However, the lack of gene modification technologies for this
model has precluded more direct functional studies.
Methods: The development of in vitro culture methods to yield P. chabaudi schizonts for
transfection and conditions for genetic modification of this rodent malaria model are reported.
Results: Independent P. chabaudi gene-integrant lines that constitutively express high levels of
green fluorescent protein throughout their life cycle have been generated.
Conclusion: Genetic modification of P. chabaudi is now possible. The production of genetically
distinct reference lines offers substantial advances to our understanding of malaria parasite biology,
especially interactions with the immune system during chronic infection.
Background
The development of transfection technologies in Plasmo-
dium have led to substantial advances in malaria research
[1-3]. The first successful transient transfection to be
reported was performed in Plasmodium gallinaceum, fol-
lowed by Plasmodium falciparum [4,5]. However, stable
gene disruption and replacement technologies were devel-
oped first for the rodent malaria parasite, Plasmodium
berghei [3,6-9], and have subsequently proved particularly
useful in analysis of proteins mediating sexual develop-
ment and transmission of the parasite through the mos-
quito vector [10-13]. Stable transformation has also been
achieved for Plasmodium yoelii [14] but P. berghei has been
the focus for the development of technical advances in
transfection [2].
However, P. berghei causes a rapid and virulent infection
leading to widespread tissue pathology and early death
without effective host immune control making the inves-
tigation of host adaptive immune responses and chronic
malaria infections challenging [15,16]. The lack of genet-
ically distinct P. berghei clones limits its use as a model for
investigations of the evolution and ecology of host-para-
site interactions [17,18]. Furthermore, transmission of P.
berghei through the mosquito vector occurs at lower tem-
peratures (18–21°C) and is longer (21 days) than trans-
mission of human or other rodent malaria parasites (>
24°C for 10–14 days) and P. falciparum. This may influ-
ence studies of parasite biology and development in the
vector as parasite-vector interactions are sensitive to tem-
perature (e.g. [19]).
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Malaria Journal 2008, 7:183 http://www.malariajournal.com/content/7/1/183In contrast, the rodent malaria parasite P. chabaudi could
provide a more relevant model for investigating anti-
malarial host immune responses because infections are
usually controlled by host immunity (reviewed in
[16,20,21]). Plasmodium chabaudi also shares a number of
life history features with the most severe human malaria
parasite, P. falciparum, including mature erythrocyte pref-
erence, synchronous schizogony, sequestration, rosetting,
antigenic variation, and acute parasitaemia which
becomes chronic [22-26]. Also, as in P. falciparum infec-
tions, the inability to control the consequences of the first
peak of parasitaemia is a major determinant of severe dis-
ease and death. In P. chabaudi and P. falciparum most
investment into sexual stages occurs after the initial peaks
of parasitaemia and commitment to gametocytes appears
to follow changes in anaemia and red cell dynamics [27-
30]. In addition, the bank of genetically distinct and phe-
notypically well-characterized clones available for P.
chabaudi is substantially larger than for all other rodent
malaria models [17].
The development of gene transformation technologies for
P. chabaudi will, therefore, provide opportunities for
experimental and analytical advances in fields as diverse
as immunology and evolutionary ecology. This paper
presents the first report of the generation of fluorescent P.
chabaudi lines that constitutively express high levels of
Green Fluorescent Protein (GFP) throughout their life-
cycle.
Methods
Preparation of parasites for transfection
To obtain parasites for transfection, male MF1 mice (10
weeks) were infected i.p. with 1 × 107 P. chabaudi parasites
from clone AJ4916. 500 μl of blood containing ring and
early trophozoite-stage parasites were collected by cardiac
puncture at 3 days post infection (5–10% parasitaemia).
Parasites were cultured for 17–18 hours at a 1.5% dilution
in complete culture medium (RPMI medium (with
NaHCO3, Hepes and L-glutamine, Invitrogen) containing
25% heat inactivated foetal calf serum (Gibco), at pH
7.25) in the presence of 10% O2, 5% CO2, 85% N2, at
32°C in upright 200 ml flasks (Ikawa) in a horizontal
shaking incubator at 30 rpm. Parasitized blood forming a
layer at the bottom of the flask was gently removed and
centrifuged at 1500 rpm for 30 sec. 5 μl of pelleted cells (1
× 106 schizonts) were used per transfection.
Transfection and selection of transformed parasites
Gfp was introduced into the genome of P. chabaudi para-
sites, using the PbGFPCON plasmid previously described
[7]. 5 μg of plasmid DNA, linearized at the Apa1 site, in 5
μl of dH2O was added to 100 μl of Amaxa nucleofectortm
test solution 88A6 (Basic Parasite Nucleofectortm solution
2) in the manufacturers' cuvette (Amaxa Biosystems). 5 μl
of schizont mix was added and electroporation was car-
ried out in an Amaxa nucleofectortm using program U33.
After electroporation, 50 μl of pre-warmed complete cul-
ture media was added and the transfection mix was imme-
diately injected i.v. into an MF1 mouse. Recipient mice
received 35 μg/ml pyrimethamine in their drinking water
(pH 3.5–5) for seven days post infection; the minimum
pyrimethamine dose required to clear P. chabaudi infec-
tions of clone AJ in 24 hours (J. Thompson, personal
observation). Giemsa-stained smears were scanned every
one to two days and parasites that produced patent infec-
tions (days 14–20) were immediately passaged to further
mice for the production of stabilate stocks.
Analysis of transformed parasites
For genetic analysis of the integration locus, DNA was iso-
lated as previously described [2] and Southern blot and
PCR analyses were performed. PCR amplifications were
carried out using Qiagen Taq DNA polymerase in the pres-
ence of 'Q solution' under the following conditions; 35
cycles; anneal, 54°C, 1 min; extend, 68°C, 3 min, dena-
ture, 94°C, 10 sec. To demonstrate integration into a ssu-
rrna locus at the 5' region, amplification was carried out
with primer Pc5'F (TTGTAAGAACGTGCTTGGTG) that is
specific for P. chabaudi ssu-rrna sequence on P. chabaudi
genome contig827, in the target region, and primer Pl5'R
(TTCCCAGTCACGACGTTG) that anneals to P. berghei d-
ssu rrna sequence in the PbGFPCON plasmid. To demon-
strate integration into the contig827 ssu-rrna locus at the
3' region, amplification was carried out with primer Pc3'R
(AGAGCCCAGCGATGAC) that is specific for P. chabaudi
contig827 ssu-rrna sequence in the integration site, and
primer Pl3'F (CAATGATTCATAAATAGTTGGAC) that
anneals to P. berghei d-ssu rrna sequence in the PbGFPCON
plasmid. To demonstrate the presence of tg-dhfr sequence,
amplification was carried out with primers L190
(CGGGATCCATGCATAAACCGGTGTGTC) + L191;
CGGGATCCAAGCTTCTGTATTTCCG. To amplify circular
PbGFPCON plasmid, amplification was carried out with
primers PlF2 (AATCATGACTTCTGTCACTGC) and Pl5'R.
Primers Pc5'R and Pc3'R anneal specifically to sequences
within P. chabaudi contig827 ssu-rrna and not to
sequences within the PbCON vector. Probe template for the
detection of tgdhfr by Southern blots was amplified using
primers L190/L191. DNA was digested with HindIII and
NheI, transferred to Hybond N+ membrane (Amersham)
and hybridized according to the manufacturers methods.
Wet preparations of live parasites expressing GFP were vis-
ualized using Openlab digital imaging (Improvision). The
development and progression of parasitaemia in trans-
formed parasites was compared to the wild type ancestor
by following six mice infected with 106 parasitized red
blood cells for each line. Infections were monitored daily
to collect red blood cell density and parasitaemia data
until day 14 post infection, when the acute phase parasitesPage 2 of 6
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Malaria Journal 2008, 7:183 http://www.malariajournal.com/content/7/1/183had been cleared. The infection dynamics of the two lines
were analysed using linear mixed-effects models, which
account for repeated measures across infections. One
mouse from each line was euthanized (day 10 and 11) so
these infections did not contribute data for the whole time
course.
Results and discussion
The optimal stage for DNA uptake by Plasmodium is
thought to be the free merozoites, released at schizogony,
that are not surrounded by red blood cell cytoplasm and
membranes.P. berghei may, therefore, be relatively amena-
ble to genetic transformation because schizonts develop-
ing in reticulocytes do not rupture in in vitro culture
conditions, so high numbers can be purified. These rup-
ture, releasing merozoites, during electroporation. In con-
trast, P. chabaudi schizonts, developing in mature red
blood cells, do not arrest in culture and cannot be purified
in such large numbers. For this reason, the transformation
efficiency of P. chabaudi is likely to be considerably lower
that that of P. berghei. The major improvements in rodent
malaria parasite transformation efficiency obtained with
the Amaxa Nucleofectortm technology [9], however,
together with the development of culture conditions that
generate mature P. chabaudi schizonts suggested to us that
transformation of P. chabaudi may now be possible.
To obtain appropriate numbers of P. chabaudi schizonts,
the in vitro culture protocol described by Mackinnon et al
[24] was adapted and scaled-up. Under these conditions,
synchronous P. chabaudi ring-stage parasites/young tro-
phozoites develop over 17–18 hours into a population of
parasites that contain > 10% mature schizonts (Figure
1A). Schizonts produced by in vitro culture of P. chabaudi
AJ blood stage parasites were transfected with the PbGFP-
CON plasmid [7] that contains an incomplete copy of the
P. berghei d-ssu-rrna as a target region for integration, and
the pyrimethamine-resistant tgdhfr-ts selectable cassette
(pyrR2) for selection of transgenic parasites (Figure 2).
Blast analysis of the P. chabaudi genome http://
www.sanger.ac.uk/cgi-bin/blast/submitblast/p_chabaudi
showed that there is highest identity (94%) between the
(A) Cultured P. chabaudi schizonts used for transfection (giemsa stain) (B-F) Fluorescent and bright field images of P. chabaudi PcGFPcon blood-stage parasitesFigure 1
(A) Cultured P. chabaudi schizonts used for transfection (giemsa stain) (B-F) Fluorescent and bright field 
images of P. chabaudi PcGFPcon blood-stage parasites. (B) two trophozoites in a rosetting red blood cell; (C) young 
trophozoite; (D) gametocyte; (E) schizont; (F) rupturing schizont; multiple infection of young and mature trophozoites (G); 
multiple infection of rings and young trophozoite (H); wild-type AJ P. chabaudi (I). Scale bar = 5 μm.Page 3 of 6
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Malaria Journal 2008, 7:183 http://www.malariajournal.com/content/7/1/183P. berghei d-ssu-rrna target region and P. chabaudi ssu-rrna
sequences on genome contig827, indicating that these are
orthologous loci. Linearized PbGFPCON DNA was intro-
duced into the parasite genome by electroporation and
recombinant parasites that express tghfr were selected by
treatment with pyrimethamine.
Integration of the PbGFPCON cassette into the P. chabaudi
genome was confirmed by PCR analysis in four independ-
ent lines and line '2.3' was selected for further genetic and
phenotypic analysis. In P. chabaudi line 2.3, PbGFPCON
integrated into the genome of contig 827 rRNA subunit,
orthologous to the P. berghei c or d-ssu-rrna that have pre-
viously been shown to be non-essential genes in rodent
malaria parasites [7]. Recombinant parasites develop to
blood-stages with no apparent defects (Figure 1B–E) and
form gametocytes that exflagellate and can infect mosqui-
toes.
Integration of PbCON into P. chabaudi ssu-rrnaFigu e 2
Integration of PbCON into P. chabaudi ssu-rrna. Schematic representation of P. chabaudi ssu-rrna locus on contig827 (A). 
Schematic representation of linearized plasmid PbCON containing the Tgdhfr-ts cassette, conferring pyrimethamine resistance 
and gfp, flanked by P. berghei d-ssu-rrna target sequences for integration (B). Schematic representation of the contig827 ssu-rrna 
locus in PcGFPCON clone 2.3, following integration of the PbCON plasmid (C). D: tgdhfr is present in PcGFPCON (lane 1) but not 
wt (lane 2) DNA; amplification with L190/L191. Circular PbGFPCON plasmid is absent in PcGFPCON (lane 3); circular PbGFPCON 
(lane 4); amplification with PlF2/Pl5'R. Verification of the 5' integration site; Pc5'F/Pl5'R amplify a product in PcGFPCON (lane 5) 
but not in wt (lane 6) DNA. Verification of the 3' integration site; Pl3'F/Pc3'R amplify a product in PcGFPCON (lane 7) but not wt 
(lane 8) DNA. E: Tgdhfr is present in the genome of PcGFPCON but not wt parasites. wt (lanes 1 and 2) and PcGFPCON (lanes 3 
and 4) genomic DNA digested with NheI (lanes 1 and 3) or HindIII (lanes 2 and 4). Integration of PcGFP into the P. chabaudi ssu-
rrna locus on contig827 results in restriction enzyme digestion products of 9.4 and 15.4 kb following NheI and HindIII digestion 
respectively. N, NheI; H, HindIII.Page 4 of 6
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cantly different to wild type P. chabaudi AJ4916 ancestral
parasites that had undergone comparable numbers of pas-
sages (Figure 3). Infections initiated with line 2.3 and
AJ4916 parasites both reached patency by microscopy on
day 3 post infection, peaked on day 7–8 and the acute
phase lasted for 14 days. More detailed analysis of para-
siteamia revealed that the lines did not differ significantly
in their average parasitaemia (F(1,10)= 0.02; P = 0.901).
The patterns observed throughout infections were similar,
though parasitaemia of line AJ4916 was significantly
lower on days 8 and 9 post infection (F(10,91) = 4.96; P <
0.0001). The lines did not differ in the patterns or the
average levels of anaemia they caused (F(1,10) = 0.001; P =
0.975). Although reversion to the wild-type genotype was
observed at a low rate after multiple blood-stage passages,
all Pc-GFPCON (line 2.3) parasites observed at day 8 of
infection were GFP-positive.
Conclusion
Plasmodium chabaudi is reproducibly accessible for genetic
transformation at an efficiency that is sufficient for
genomic integration of introduced genes. The develop-
ment of technologies that allow disruption or modifica-
tion of gene expression in P. chabaudi, thus, opens the way
for direct functional analysis of parasite proteins through-
out both acute and chronic stages of an in vivo malaria
infection, including those that have been implicated in
modulation of the host immune response [31]. The gen-
eration of stable fluorescent P. chabaudi parasite lines also
offers the opportunity for imaging of direct interactions
between the parasite and host cells within a variety of host
tissues.
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